中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
维拉帕米相关物D |
5,5'-((2-(3,4-Dimethoxyphenyl)ethyl)imino)bis(2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile)hydrochloride |
190850-50-1 |
C42H58ClN3O6 |
|
维拉帕米杂质O |
Desisopropyl N-propyl verapamil |
959011-16-6 |
C27H38N2O4 |
|
维拉帕米杂质N(EP) |
5,5'-(Methylimino)bis(2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile) |
2086274-75-9 |
C33H47N3O4 |
|
维拉帕米杂质 |
3-[N-methyl-N-(2-{3,4-dimethoxy-phenyl}-ethyl)amino]-propanol |
85175-54-8 |
C14H23NO3 |
|
维拉帕米杂质 |
D 703 |
67018-80-8 |
C26H36N2O4 |
|
维拉帕米 |
(2S)-(-)-gallopamil |
36622-40-9 |
C28H40N2O5 |
|
维拉帕米 |
Verapamil |
52-53-9 |
C27H38N2O4 |
|
维多氟拉迪莫 |
2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid |
717824-30-1 |
C20H18FNO4 |
|
维塞诺钠盐 |
Vercirnon sodium |
886214-18-2 |
C22H20ClN2NaO4S |
|
维兰特罗杂质3 |
FE6Njg54F9 |
503070-62-0 |
C23H31Cl2NO5 |
|
维兰特罗杂质 |
[({2-[(6-bromohexyl)oxy]ethyl}oxy)methyl]benzene |
503068-31-3 |
C15H23BrO2 |
|
维兰特罗三苯乙酸盐 |
vilanterol trifenatate |
503070-58-4 |
C20H16O2*C24H33Cl2NO5 |
|
维兰特罗 |
vilanterol |
503068-34-6 |
C24H33Cl2NO5 |
|
绕丹酸铵盐 |
Ammonium rhodanilate |
10380-20-8 |
C16H14CrN6S4*H4N |
|
结晶紫阳离子 |
{4-[Bis-(4-dimethylamino-phenyl)-methylene]-cyclohexa-2,5-dienylidene}-dimethyl-ammonium |
14426-25-6 |
C25H30N3 |
|
结晶紫 |
tris[4-(dimethylamino)phenyl]methane |
603-48-5 |
C25H31N3 |
|
细辛脑 |
α-asarone |
2883-98-9 |
C12H16O3 |
|
细胞色素P45014a-脱甲基酶抑制剂1J |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-methylbenzyl)-amino]-2-propanol |
1155361-08-2 |
C22H24F2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1I |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(4-bromobenzyl)-amino]-2-propanol |
1155361-07-1 |
C21H21BrF2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1H |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-bromobenzyl)-amino]-2-propanol |
1155361-06-0 |
C21H21BrF2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1E |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-chlorobenzyl)-amino]-2-propanol |
1155361-03-7 |
C21H21ClF2N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1D |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(4-fluorobenzyl)-amino]-2-propanol |
1155361-02-6 |
C21H21F3N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1C |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(3-fluorobenzyl)-amino]-2-propanol |
1155361-01-5 |
C21H21F3N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1B |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-(2-fluorobenzyl)-amino]-2-propanol |
1155361-00-4 |
C21H21F3N4O |
|
细胞色素P45014a-脱甲基酶抑制剂1A |
1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[N-allyl-N-benzyl-amino]-2-propanol |
1155360-99-8 |
C21H22F2N4O |
|
细皱青霉素-FORM |
Rugulosin |
23537-16-8 |
C30H22O10 |
|
细叶青蒌藤素 |
(+)-crotepoxide |
20421-13-0 |
C18H18O8 |
|
组胺三氟甲基-甲苯胺 |
HTMT |
103827-16-3 |
C19H25F3N4O |
|
组织蛋白酶D抑制剂 |
1-(3-Methylphenyl)butan-2-amine |
147702-27-0 |
C11H17N |
|
线粒体融合启动子M1 |
4-chloro-2-[C-methyl-N-(2,4,6-trichloroanilino)carbonimidoyl]phenol |
219315-22-7 |
C14H10Cl4N2O |
|
线性酚醛树脂 |
4-Tert-butylphenol;formaldehyde;4-(2-methylbutan-2-yl)phenol |
65733-76-8 |
C22H32O3 |
|
纽帕泛 |
Nupafant |
139133-27-0 |
C23H32N4O3S |
|
纳莫雷特 |
2-Biphenyl-4-yl-butyric acid; compound with 2-dimethylamino-ethanol |
1234-71-5 |
C4H11NO*C16H16O2 |
|
纳美酮 |
(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-(3-methylbut-2-enyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride |
—— |
C21H26ClNO4 |
|
纳美酮 |
nalmexone |
16676-26-9 |
C21H25NO4 |
|
纳美芬杂质 |
2,2'-Bisnalmefene |
176220-84-1 |
C42H48N2O6 |
|
纳美芬 |
nalmefene |
55096-26-9 |
C21H25NO3 |
|
纳洛酮甲醚 |
N-Allyl-N-demethyl-14-hydroxy-(+)-dihydrocodeinone |
131830-09-6 |
C20H23NO4 |
|
纳洛酮杂质E |
2,2'-Bisnaloxone |
211738-08-8 |
C38H40N2O8 |
|
纳洛酮杂质3 |
2Ujb71xti6 |
2139253-68-0 |
C19H21NO5 |
|
纳洛酮杂质1 |
naloxone |
70866-64-7 |
C20H23NO4 |
|
纳洛酮杂质 |
3-allylnaloxone |
1352085-46-1 |
C22H25NO4 |
|
纳洛酮EP杂质F |
EB0J6TS92A |
2139253-69-1 |
C19H21NO5 |
|
纳洛酮-d5 |
Naloxone-d5 |
1261079-38-2 |
C19H21NO4 |
|
纳洛酮-3,14-二乙酸酯 |
naloxone 3,14-diacetate |
50510-01-5 |
C23H25NO6 |
|
纳洛酮 |
Naloxone |
465-65-6 |
C19H21NO4 |
|
纳洛肼二盐酸盐 |
(4R,4aS,7aR,12bS)-7-[[(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene]hydrazinylidene]-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol |
82824-01-9 |
C38H42N4O6 |
|
纳洛塞醇 |
naloxegol |
854601-70-0 |
C34H53NO11 |
|
纳曲醇D4 |
(4R,4aS,7R,7aR,12bS)-3-[(2,2,3,3-tetradeuteriocyclopropyl)methyl]-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol |
1279034-32-0 |
C20H25NO4 |
|
纳曲酮苯基肟 |
Naltrexone phenyl oxime |
115160-07-1 |
C26H28N2O4 |
|